A randomized placebo-controlled trial of duloxetine in patients with major depressive disorder and associated painful physical symptoms

By Gaynor Paula J.   Gopal Murali   Zheng Wei   Martinez James M.   Robinson Michael J.   Marangell Lauren B.  

Current Medical Research and Opinion, Vol. 27, Iss. 10, 2011-10 ,pp. : 1849-1858

Informa Healthcare

Access to resources Recommend Favorite

Duloxetine versus escitalopram and placebo in the treatment of patients with major depressive disorder: onset of antidepressant action, a non-inferiority study

By Nierenberg Andrew A.   Greist John H.   Mallinckrodt Craig H.   Prakash Apurva   Sambunaris Angelo   Tollefson Gary D.   Wohlreich Madelaine M.  

Current Medical Research and Opinion, Vol. 23, Iss. 2, 2007-02 ,pp. : 401-416

Informa Healthcare

Access to resources Recommend Favorite

Duloxetine versus escitalopram and placebo: an 8-month, double-blind trial in patients with major depressive disorder

By Pigott Teresa A.   Prakash Apurva   Arnold Lesley M.   Aaronson Scott T.   Mallinckrodt Craig H.   Wohlreich Madelaine M.  

Current Medical Research and Opinion, Vol. 23, Iss. 6, 2007-06 ,pp. : 1303-1318

Informa Healthcare

Access to resources Recommend Favorite

A comparative study of the efficacy of acute and continuation treatment with escitalopram versus duloxetine in patients with major depressive disorder

By Wade A.   Gembert K.   Florea I.  

Current Medical Research and Opinion, Vol. 23, Iss. 7, 2007-07 ,pp. : 1605-1614

Informa Healthcare

Access to resources Recommend Favorite

Suicides and Suicide Attempts during Long-Term Treatment with Antidepressants: A Meta-Analysis of 29 Placebo-Controlled Studies Including 6,934 Patients with Major Depressive Disorder

By  

Psychotherapy and Psychosomatics, Vol. 85, Iss. 3, 2016-04 ,pp. : 171-179

Karger

Access to resources Recommend Favorite